Home › Stocks › KAPA

KAPA — KAIROS PHARMA LTD

Reported value held$2.46M
Funds holding (latest)30
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)6
Institutional value$57.80K · 35.21K sh
New / Add / Cut / Exit1 / 0 / 5 / 9 · Updated 2026-11-16
Top-5 / Top-10 concentration97.1% / 100.0%
Institutional holdings change Reducing -90.4% (-306.81K sh)
Institutional value change Down -58.9%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingBuy
Analysts covering—
12-month price target$13.00 (+2836.5%)
Last price at fetch$0.44
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)+0.00
Revision score (year)+0.00
Fiscal quarter end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -0.77 — -0.77 -0.77 1 —
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -2.59 — -2.59 -2.59 1 —
Dec 2027 -4.69 — -4.69 -4.69 1 —
Dec 2028 -5.11 — -5.11 -5.11 1 —

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 6 SEC-registered investment managers reported holding KAPA (KAIROS PHARMA LTD) in their latest 13F filings, with a combined reported value of $57.80K across 35.21K shares. That is -90.4% by share count (-306.81K shares) versus the previous quarter, while reported value moved -58.9%. Ownership is concentrated: the five largest holders account for 97.1% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 1 opened new positions, 5 trimmed, 9 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of KAIROS PHARMA LTD (KAPA) include ARMISTICE CAPITAL, LLC, UMB Bank, n.a., Citadel Advisors, ranked by reported 13F value among the 30 institutional holders on this page.

KAPA is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 6 35.21K $57.80K -90.4%
Q2 2026 14 1.02M $392.13K -6.5%
Q1 2026 11 601.06K $341.51K -5.3%
Q4 2025 14 855.72K $607.47K +23.9%
Q3 2025 14 445.02K $505.84K +2.0%
Q2 2025 10 218.72K $172.89K +7.2%
Q1 2025 8 1.58M $1.46M -26.5%
Q4 2024 5 406.60K $618.27K -58.3%

Over the 8 quarters shown, institutional share counts decreased 91% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-58.3%).

Top Institutional Holders (Q3 2026) — 6 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 13.60K $22.30K 0.00% Reduce
VANGUARD CAPITAL MANAGEMENT LLC 9.71K $15.92K 0.00% Reduce
VANGUARD FIDUCIARY TRUST CO 6.87K $11.27K 0.00% Reduce
Nuveen, LLC 2.52K $4.18K 0.00% New
Tower Research Capital LLC (TRC) 1.49K $2.44K 0.00% Reduce
UBS Group AG 1.03K $1.69K 0.00% Reduce

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 14 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 309.83K $118.88K 0.00% New
VANGUARD CAPITAL MANAGEMENT LLC 231.88K $89.04K 0.00% Hold
Virtu Financial LLC 82.09K $31.00K 0.00% New
GEODE CAPITAL MANAGEMENT, LLC 78.92K $30.28K 0.00% New
Geode Capital Management 78.92K $30.28K 0.00% Reduce
VANGUARD FIDUCIARY TRUST CO 63.88K $24.53K 0.00% Hold
SevenBridge Financial Group, LLC 44.29K $17.09K 0.00% Hold
Aptus Capital Advisors, LLC 44.29K $16.99K 0.00% Hold
JANE STREET GROUP, LLC 33.75K $12.95K 0.00% New
SUSQUEHANNA INTERNATIONAL GROUP, LLP 29.29K $11.24K 0.00% New
XTX Topco Ltd 14.92K $5.72K 0.00% New
UBS Group AG 6.26K $2.40K 0.00% New
Tower Research Capital LLC (TRC) 3.73K $1.43K 0.00% Reduce
BARCLAYS PLC 723 $277 0.00% New

Q1 2026 — 11 funds

FundSharesValuePortfolio WeightChange
VANGUARD CAPITAL MANAGEMENT LLC 231.88K $129.62K 0.00% New
Geode Capital Management 111.29K $62.21K 0.00% Add
VANGUARD FIDUCIARY TRUST CO 63.88K $35.71K 0.00% New
SevenBridge Financial Group, LLC 44.29K $30.33K 0.01% Hold
Aptus Capital Advisors, LLC 44.29K $24.76K 0.00% Hold
Two Sigma Investments 39.54K $22.11K 0.00% Reduce
STATE STREET CORP 24.10K $13.47K 0.00% Hold
HRT FINANCIAL LP 21.57K $12.00K 0.00% Add
TWO SIGMA SECURITIES, LLC 16.25K $9.08K 0.00% New
Tower Research Capital LLC (TRC) 3.96K $2.21K 0.00% Reduce
Citigroup Inc 10 $6 0.00% New

Q4 2025 — 14 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 321.74K $228.43K 0.00% New
Vanguard Group 131.83K $93.60K 0.00% Hold
Two Sigma Investments 94.01K $66.75K 0.00% Add
Geode Capital Management 72.83K $51.71K 0.00% Add
XTX Topco Ltd 48.49K $34.43K 0.00% Add
SevenBridge Financial Group, LLC 44.29K $31.89K 0.01% Hold
Aptus Capital Advisors, LLC 44.29K $31.44K 0.00% Hold
STATE STREET CORP 24.10K $17.11K 0.00% Hold
HRT FINANCIAL LP 21.32K $15.00K 0.00% New
Virtu Financial LLC 20.28K $14.00K 0.00% New
TWO SIGMA ADVISERS, LP 15.14K $10.75K 0.00% New
OSAIC HOLDINGS, INC. 13.04K $9.26K 0.00% New
Tower Research Capital LLC (TRC) 4.23K $3.00K 0.00% Reduce
Bank of America Corp 134 $95 0.00% Reduce

Q3 2025 — 14 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 131.83K $154.24K 0.00% New
Geode Capital Management 65.80K $76.98K 0.00% Add
Two Sigma Investments 45.79K $53.57K 0.00% New
Aptus Capital Advisors, LLC 44.29K $51.81K 0.00% Hold
SevenBridge Financial Group, LLC 44.29K $37.65K 0.01% Hold
TWO SIGMA SECURITIES, LLC 24.89K $29.13K 0.00% Add
STATE STREET CORP 24.10K $28.20K 0.00% New
FNY Investment Advisers, LLC 23.50K $27.00K 0.01% New
Quadrature Capital Ltd 14.89K $17.42K 0.00% New
XTX Topco Ltd 12.41K $14.52K 0.00% Reduce
UBS Group AG 5.98K $7.00K 0.00% Reduce
Tower Research Capital LLC (TRC) 5.96K $6.97K 0.00% Add
ROYAL BANK OF CANADA 1.00K $1.00K 0.00% New
Bank of America Corp 304 $356 0.00% Add

Q2 2025 — 10 funds

FundSharesValuePortfolio WeightChange
SevenBridge Financial Group, LLC 44.29K $49.60K 0.01% Hold
XTX Topco Ltd 62.75K $44.49K 0.00% New
Aptus Capital Advisors, LLC 44.29K $31.40K 0.00% Hold
Geode Capital Management 21.80K $15.46K 0.00% Add
TWO SIGMA SECURITIES, LLC 13.55K $9.61K 0.00% New
HRT FINANCIAL LP 13.24K $9.00K 0.00% New
UBS Group AG 9.46K $6.71K 0.00% Add
Citigroup Inc 5.50K $3.90K 0.00% New
Tower Research Capital LLC (TRC) 3.80K $2.69K 0.00% New
Bank of America Corp 51 $36 0.00% Add

View all 30 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
JANE STREET GROUP, LLC 13.60K 33.75K — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 9.71K 231.88K 231.88K — — — — — —
VANGUARD FIDUCIARY TRUST CO 6.87K 63.88K 63.88K — — — — — —
Nuveen, LLC 2.52K — — — — — — — —
Tower Research Capital LLC (TRC) 1.49K 3.73K 3.96K 4.23K 5.96K 3.80K — — —
UBS Group AG 1.03K 6.26K — — 5.98K 9.46K 2.79K 10.85K —
ARMISTICE CAPITAL, LLC — — — — — — 1.40M — —
UMB Bank, n.a. — — — — — — — 371.12K —
Citadel Advisors — 309.83K — 321.74K — — 13.23K 10.97K —
Vanguard Group — — — 131.83K 131.83K — — — —
Geode Capital Management — 78.92K 111.29K 72.83K 65.80K 21.80K 20.43K — —
Two Sigma Investments — — 39.54K 94.01K 45.79K — — — —
Aptus Capital Advisors, LLC — 44.29K 44.29K 44.29K 44.29K 44.29K 44.29K — —
Virtu Financial LLC — 82.09K — 20.28K — — — 13.66K 32.71K
SevenBridge Financial Group, LLC — 44.29K 44.29K 44.29K 44.29K 44.29K 44.29K — —
Scientech Research LLC — — — — — — 48.20K — —
XTX Topco Ltd — 14.92K — 48.49K 12.41K 62.75K — — —
GEODE CAPITAL MANAGEMENT, LLC — 78.92K — — — — — — —
TWO SIGMA SECURITIES, LLC — — 16.25K — 24.89K 13.55K — — —
STATE STREET CORP — — 24.10K 24.10K 24.10K — — — —

Download holders (CSV)

FAQ

Which funds hold KAPA?

As of 2026-Q3, 6 institutional funds reported holding KAPA (KAIROS PHARMA LTD) in SEC 13F filings, with a combined reported value of $57.80K.

How many shares of KAPA do institutions own?

13F filers reported 35.21K shares of KAPA, worth $57.80K in aggregate at the end of 2026-Q3.

Is institutional ownership of KAPA rising or falling?

Share counts moved -90.4% versus the prior quarter — distribution.

Who are the top institutional holders of KAPA?

The largest 13F holders are ARMISTICE CAPITAL, LLC, UMB Bank, n.a., Citadel Advisors, Vanguard Group, Scientech Research LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of KAIROS PHARMA LTD?

The major shareholders of KAIROS PHARMA LTD (KAPA) by reported 13F value are ARMISTICE CAPITAL, LLC, UMB Bank, n.a., Citadel Advisors, Vanguard Group, Scientech Research LLC, among 30 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own KAPA" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/KAPA/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →